Greenwich LifeSciences, Inc.
GLSI- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001799788
In the last 90 days, Greenwich LifeSciences, Inc. insiders filed 3 open-market purchases and 0 sales; 57 institutions reported holding it in 13F filings for Q2 2026, worth $39.6M in total; no superinvestor holds it.
13F holders, Q1 2021
Institutional positions in Greenwich LifeSciences, Inc. as of Mar 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 19
- No complete 13F data for Q4 2020
- Shares held
- 259.8K
- No complete 13F data for Q4 2020
- Total value
- $8.90M
- No complete 13F data for Q4 2020
Holders and value by quarter
Institutions reporting GLSI on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 57 | $39.6M |
| Q1 2026 | 64 | $41.1M |
| Q4 2025 | 50 | $27.9M |
| Q3 2025 | 51 | $12.1M |
| Q2 2025 | 51 | $11.2M |
| Q1 2025 | 46 | $11.1M |
| Q4 2024 | 42 | $13.3M |
| Q3 2024 | 39 | $16.4M |
| Q2 2024 | 34 | $17.6M |
| Q1 2024 | 31 | $12.9M |
| Q4 2023 | 27 | $5.64M |
| Q3 2023 | 24 | $4.75M |
| Q2 2023 | 23 | $6.06M |
| Q1 2023 | 28 | $11.4M |
| Q4 2022 | 22 | $10.2M |
| Q3 2022 | 21 | $7.21M |
| Q2 2022 | 34 | $8.74M |
| Q1 2022 | 34 | $18.3M |
| Q4 2021 | 35 | $19.4M |
| Q3 2021 | 36 | $31.9M |
| Q2 2021 | 30 | $36.4M |
| Q1 2021 | 19 | $8.90M |
Institutions, Q1 2021
Shares, value and share of portfolio for each institution holding Greenwich LifeSciences, Inc..
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 106,261 | $3.62M | 0.00% | – | – |
| BlackRock Inc. | 63,540 | $2.17M | 0.00% | – | – |
| Millennium Management LLC | 19,450 | $663.0K | 0.00% | – | – |
| Geode Capital Management, LLC | 14,463 | $493.0K | 0.00% | – | – |
| HRT Financial LP | 10,952 | $373.0K | 0.00% | – | – |
| Jacobs Levy Equity Management, Inc | 10,809 | $368.0K | 0.00% | – | – |
| SkyOak Wealth, LLC | 7,405 | $293.0K | 0.08% | – | – |
| Creative Planning | 7,351 | $251.0K | 0.00% | – | – |
| Citadel Advisors LLC | 7,114 | $243.0K | 0.00% | – | – |
| Morgan Stanley | 4,622 | $158.0K | 0.00% | – | – |
| Royal Bank of Canada | 2,800 | $95.0K | 0.00% | – | – |
| Tower Research Capital LLC (TRC) | 1,853 | $63.0K | 0.00% | – | – |
| Wells Fargo & Company | 1,134 | $38.0K | 0.00% | – | – |
| Signaturefd, LLC | 556 | $19.0K | 0.00% | – | – |
| Citigroup Inc | 515 | $18.0K | 0.00% | – | – |
| Bank of America Corp | 373 | $13.0K | 0.00% | – | – |
| UBS Group AG | 309 | $11.0K | 0.00% | – | – |
| Federation des caisses Desjardins du Quebec | 200 | $6.82K | 0.00% | – | – |
| North Star Investment Management Corp. | 51 | $2.00K | 0.00% | – | – |